Processing...
We search every university research program in the country, find the trials your pet qualifies for, and handle the application on your behalf.
We only feature active trials from accredited universities nationwide.
100+
Active clinical trials tracked
25
Accredited university partners
34
Cancer types covered
Active oncology clinical trials across 34 cancer types. Hover any segment to explore, or see the top conditions in the panel.
14.8% of covered types
10.4% of covered types
9.8% of covered types
8.2% of covered types
* Some trials cover multiple cancer types and are counted once per type. Total counted (183) may exceed unique trials (100).
Over 100 oncology clinical trials are currently underway across the United States. We have highlighted a selection below to illustrate the collaborative opportunities available to you and your pet today.
A fully funded trial lasting 4 months to treat oral squamous cell carcinoma in dogs using a small molecule inhibitor currently used in human cancer treatment.
10–15 minutes. Diagnosis, stage, location, and how far you'll travel.
Instant results. Every trial at every university checked against your pet's profile simultaneously.
No forms to find. No coordinators to cold-call. The research team receives everything and contacts you directly.
Learn more before you search
Stripe is trusted by millions of businesses worldwide, including:
Expert insights and guides to help you navigate pet cancer clinical trials
Apocrine gland anal sac adenocarcinoma is an aggressive tumor that often spreads to lymph nodes early and can send calcium levels dangerously high. But with surgery and modern multimodal care, many dogs live well beyond two years. This guide explains the disease, its costs, and the clinical trials expanding options in 2026.
By Brycen Levings
Read MoreHistiocytic sarcoma is an aggressive cancer of the immune system with a strong breed signature — Bernese Mountain Dogs, Flat-Coated Retrievers, Rottweilers, and Golden Retrievers are especially at risk. This guide explains the localized and disseminated forms, what treatment costs, and the clinical trials expanding options in 2026.
By Brycen Levings
Read MoreTransitional cell carcinoma is the most common cancer of the canine urinary tract, and it usually develops in the worst possible spot for surgery. But it's also well understood at the molecular level, giving vets strong diagnostic insight into the disease and a growing list of targeted trial options. Here's what to know in 2026.
By Brycen Levings
Read More